Vocal fold fibroblasts immunoregulate activated macrophage phenotype

Cytokine

Volumn 61, Issue 1, 2013, Pages 228-236

  King, Suzanne N ^a   Chen, Fei ^b   Jetté, Marie E ^a   Thibeault, Susan L ^a,c  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF WISCONSIN   (United States)

Author keywords

Fibroblasts; Macrophage; Polyp; Scar; Vocal fold

Indexed keywords

CD14 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; COCULTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; IN VITRO STUDY; INFLAMMATION; INTRACELLULAR SIGNALING; MACROPHAGE ACTIVATION; MONOCYTE; PARACRINE SIGNALING; POLYP; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCAR; VOCAL CORD;

ANTIGENS, CD14; CELL ADHESION; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINES; FIBROBLASTS; HUMANS; INFLAMMATION; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; VOCAL CORDS; WOUND HEALING;

EID: 84869870887     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.09.023     Document Type: Article

References (42)

1. Catten M., Gray S.D., Hammond T.H., Zhou R., Hammond E. Analysis of cellular location and concentration in vocal fold lamina propria. Otolaryngol Head Neck Surg 1998, 118(5):663-667.
2. Hansen J.K., Thibeault S.L. Current understanding and review of the literature: vocal fold scarring. J Voice 2006, 20(1):110-120.
3. Ingerslev H.C., Ossum C.G., Lindenstrom T., Nielsen M.E. Fibroblasts express immune relevant genes and are important sentinel cells during tissue damage in rainbow trout (Oncorhynchus mykiss). PLoS One 2010, 5(2):e9304.
4. Zhang X., Mosser D.M. Macrophage activation by endogenous danger signals. J Pathol 2008, 214(2):161-178.
5. Gray S.D. Cellular physiology of the vocal folds. Otolaryngol Clin North Am 2000, 33(4):679-698.
6. Chen X., Thibeault S.L. Characteristics of age-related changes in cultured human vocal fold fibroblasts. Laryngoscope 2008, 118(9):1700-1704.
7. Branski R.C., Perera P., Verdolini K., Rosen C.A., Hebda P.A., Agarwal S. Dynamic biomechanical strain inhibits IL-1beta-induced inflammation in vocal fold fibroblasts. J Voice 2007, 21(6):651-660.
8. Branski R.C., Zhou H., Sandulache V.C., Chen J., Felsen D., Kraus D.H. Cyclooxygenase-2 signaling in vocal fold fibroblasts. Laryngoscope 2010, 120(9):1826-1831.
9. Lim X., Bless D.M., Munoz-Del-Rio A., Welham N.V. Changes in cytokine signaling and extracellular matrix production induced by inflammatory factors in cultured vocal fold fibroblasts. Ann Otol Rhinol Laryngol 2008, 117(3):227-238.
10. Zhou H., Felsen D., Sandulache V.C., Amin M.R., Kraus D.H., Branski R.C. Prostaglandin (PG)E2 exhibits antifibrotic activity in vocal fold fibroblasts. Laryngoscope 2011, 121(6):1261-1265.
11. Chen X., Thibeault S.L. Biocompatibility of a synthetic extracellular matrix on immortalized vocal fold fibroblasts in 3-D culture. Acta Biomater 2010, 6(8):2940-2948.
12. Lu Y., Liu Y., Fukuda K., Nakamura Y., Kumagai N., Nishida T. Inhibition by triptolide of chemokine, proinflammatory cytokine, and adhesion molecule expression induced by lipopolysaccharide in corneal fibroblasts. Invest Ophthalmol Vis Sci 2006, 47(9):3796-3800.
13. Holt D.J., Chamberlain L.M., Grainger D.W. Cell-cell signaling in co-cultures of macrophages and fibroblasts. Biomaterials 2010, 31(36):9382-9394.
14. Wang J., Hori K., Ding J., Huang Y., Kwan P., Ladak A., et al. Toll-like receptors expressed by dermal fibroblasts contribute to hypertrophic scarring. J Cell Physiol 2011, 226(5):1265-1273.
15. Welham N.V., Lim X., Tateya I., Bless D.M. Inflammatory factor profiles one hour following vocal fold injury. Ann Otol Rhinol Laryngol 2008, 117(2):145-152.
16. Thibeault S.L., Duflo S. Inflammatory cytokine responses to synthetic extracellular matrix injection to the vocal fold lamina propria. Ann Otol Rhinol Laryngol 2008, 117(3):221-226.
17. Laskin D.L. Macrophages and inflammatory mediators in chemical toxicity: a battle of forces. Chem Res Toxicol 2009, 22(8):1376-1385.
18. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008, 8(12):958-969.
19. Hanson S.E., King S.N., Kim J., Chen X., Thibeault S.L., Hematti P. The effect of mesenchymal stromal cell-hyaluronic acid hydrogel constructs on immunophenotype of macrophages. Tissue Eng Part A 2011, 17(19-20):2463-2471.
20. Song E., Ouyang N., Horbelt M., Antus B., Wang M., Exton M.S. Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts. Cell Immunol 2000, 204(1):19-28.
21. Thibeault S.L., Li W., Bartley S. A method for identification of vocal fold lamina propria fibroblasts in culture. Otolaryngol Head Neck Surg 2008, 139(6):816-822.
22. Jette ME, Hayer SD, Thibeault SL. Characterization of human vocal fold fibroblasts derived from chronic scar. Laryngoscope; in press.
23. Kim J., Hematti P. Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages. Exp Hematol 2009, 37(12):1445-1453.
24. Buckley C.D. Why does chronic inflammation persist: an unexpected role for fibroblasts. Immunol Lett 2011, 138(1):12-14.
25. Duflo S.M., Thibeault S.L., Li W., Smith M.E., Schade G., Hess M.M. Differential gene expression profiling of vocal fold polyps and reinke's edema by complementary DNA microarray. Ann Otol Rhinol Laryngol 2006, 115(9):703-714.
26. Rousseau B., Ge P., French L.C., Zealear D.L., Thibeault S.L., Ossoff R.H. Experimentally induced phonation increases matrix metalloproteinase-1 gene expression in normal rabbit vocal fold. Otolaryngol Head Neck Surg 2008, 138(1):62-68.
27. Swanson E.R., Ohno T., Abdollahian D., Garrett C.G., Rousseau B. Effects of raised-intensity phonation on inflammatory mediator gene expression in normal rabbit vocal fold. Otolaryngol Head Neck Surg 2010, 143(4):567-572.
28. Verdolini K., Rosen C.A., Branski R.C., Hebda P.A. Shifts in biochemical markers associated with wound healing in laryngeal secretions following phonotrauma: a preliminary study. Ann Otol Rhinol Laryngol 2003, 112(12):1021-1025.
29. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995, 13:251-276.
30. Allen J.S., Eisma R., Leonard G., Lafreniere D., Kreutzer D. Interleukin-8 expression in human nasal polyps. Otolaryngol Head Neck Surg 1997, 117(5):535-541.
31. Pawankar R. Nasal polyposis: an update: editorial review. Curr Opin Allergy Clin Immunol 2003, 3(1):1-6.
32. Thibeault S.L., Bless D.M., Gray S.D. Interstitial protein alterations in rabbit vocal fold with scar. J Voice 2003, 17(3):377-383.
33. Rousseau B., Hirano S., Chan R.W., Welham N.V., Thibeault S.L., Ford C.N., et al. Characterization of chronic vocal fold scarring in a rabbit model. J Voice 2004, 18(1):116-124.
34. Fiorentino D.F., Zlotnik A., Mosmann T.R., Howard M., O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991, 147(11):3815-3822.
35. Sun L., Louie M.C., Vannella K.M., Wilke C.A., LeVine A.M., Moore B.B., et al. New concepts of IL-10-induced lung fibrosis: fibrocyte recruitment and M2 activation in a CCL2/CCR2 axis. Am J Physiol Lung Cell Mol Physiol 2011, 300(3):L341-L353.
36. Ma W., Lim W., Gee K., Aucoin S., Nandan D., Kozlowski M., et al. The p38 mitogen-activated kinase pathway regulates the human interleukin-10 promoter via the activation of Sp1 transcription factor in lipopolysaccharide-stimulated human macrophages. J Biol Chem 2001, 276(17):13664-13674.
37. Thibeault S.L., Rousseau B., Welham N.V., Hirano S., Bless D.M. Hyaluronan levels in acute vocal fold scar. Laryngoscope 2004, 114(4):760-764.
38. Kaufmann A., Gemsa D., Sprenger H. Differential desensitization of lipopolysaccharide-inducible chemokine gene expression in human monocytes and macrophages. Eur J Immunol 2000, 30(6):1562-1567.
39. Schindler R., Mancilla J., Endres S., Ghorbani R., Clark S.C., Dinarello C.A. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 1990, 75(1):40-47.
40. Denis M. Interleukin-6 in mouse hypersensitivity pneumonitis: Changes in lung free cells following depletion of endogenous IL-6 or direct administration of IL-6. J Leukocyte Biol 1992, 52(2):197-201.
41. Prud'homme G.J. Pathobiology of transforming growth factor beta in cancer, fibrosis and immunologic disease, and therapeutic considerations. Lab Invest 2007, 87(11):1077-1091.
42. Fadok V.A., Bratton D.L., Konowal A., Freed P.W., Westcott J.Y., Henson P.M. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 1998, 101(4):890-898.